|
 |
| |
 |
|
|
|
|
| |
management team
|
|
 |
Victoria Sluzky, Ph.D. |
|
| |
Vice President, Quality and Analytical Chemistry
Dr. Sluzky joined BioMarin in February 2003 and
currently serves as vice president of Quality and
Analytical Chemistry. Her responsibilities include
oversight of Quality Control, Quality Assurance,
Validation and Analytical Chemistry groups. Prior
to coming to BioMarin, Dr. Sluzky was Director of
Analytical and Formulation Development at Onyx Pharmaceuticals,
where she was responsible for developing in-process,
characterization and stability assays for recombinant
adenoviruses, as well as managing formulation development
efforts. From 1992 to 1999, Dr. Sluzky was involved
in pharmaceutical research and development for various
biotechnology products ranging from small molecules
and peptides to proteins, first at Scios and then
at COR Therapeutics (now Millennium Pharmaceuticals).
Dr. Sluzky has contributed to numerous regulatory
submissions and peer reviewed publications. She
holds a Ph.D. in Chemical Engineering from MIT and
a B.S. (also in Chemical Engineering) from Stanford
University. |
|
| |
|
|
|
|
|
